文献速递甲状腺疾病

Galectin-3基因rs4644多态性与分化型甲状腺癌风险及转录组影响

Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
PubMed 文献 · Thyroid · 2021-03-02

该研究通过病例对照分析发现rs4644 AA基因型与分化型甲状腺癌风险降低相关(ORadj=0.66),并利用CRISPR/Cas9构建同源细胞系,通过RNA-seq揭示rs4644通过调节TTF-1影响下游基因转录。

要点

  • rs4644 AA基因型与DTC风险降低相关(ORadj=0.66, 95%CI 0.46-0.93, P=0.02)。
  • rs4644影响Galectin-3作为转录共调节因子,改变34个基因表达。
  • HES1、HSPA6、SPC24、NHS表达呈rs4644依赖性,并在GTEx甲状腺组织中验证。

核心结论

  • rs4644是甲状腺中的反式表达数量性状位点,通过调节TTF-1影响下游基因转录,AA基因型与DTC风险降低相关。

研究设计与样本

  • 病例对照关联研究纳入1223例对照和1142例无关连续DTC患者,评估rs4644-P64H与DTC风险关联。
  • 使用非恶性细胞系Nthy-Ori(rs4644-C/A)和CRISPR/Cas9技术生成rs4644-A/A或rs4644-C/C纯合的同源细胞,通过RNA-seq分析转录组。

主要发现

  • rs4644 AA基因型与DTC风险降低相关(相比CC,ORadj=0.66;95%CI=0.46-0.93;P=0.02)。
  • rs4644影响Galectin-3作为转录共调节因子,共影响34个基因,其中HES1、HSPA6、SPC24、NHS表达呈rs4644依赖性(HES1为CC>AA,其余为AA>CC),并在574份GTEx甲状腺组织中验证。
  • 这些基因的表达受LGALS3沉默调节,且Nthy-Ori细胞中TTF-1相互作用呈基因型依赖性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Galectin-3 (LGALS3) is an important glycoprotein involved in the malignant transformation of thyrocytes acting in the extracellular matrix, cytoplasm, and nucleus where it regulates TTF-1 and TCF4 transcription factors. Within LGALS3 gene, a common single-nucleotide polymorphism (SNP) (c.191C>A, p.Pro64His; rs4644) encoding for the variant Proline to Histidine at codon 64 has been extensively studied. However, data on rs4644 in the context of thyroid cancer are lacking. Thus, the aim of the present work was to evaluate the role of the rs4644 SNP as risk factor for differentiated thyroid cancer (DTC) and to determine the effect on the transcriptome in thyrocytes. Methods: A case/control association study in 1223 controls and 1142 unrelated consecutive DTC patients was carried out to evaluate the association between rs4644-P64H and the risk of DTC. We used the nonmalignant cell line Nthy-Ori (rs4644-C/A) and the CRISPR/Cas9 technique to generate isogenic cells carrying either the rs4644-A/A or rs4644-C/C homozygosis. Then, the transcriptome of the derivative and unmodified parental cells was analyzed by RNA-seq. Genes differentially expressed were validated by quantitative reverse transcription PCR and further tested in the parental Nthy-Ori cells after LGALS3 gene silencing, to investigate whether the expression of target genes was dependent on galectin-3 levels. Results: rs4644 AA genotype was associated with a reduced risk of DTC (compared with CC, ORadj = 0.66; 95% confidence interval = 0.46-0.93; Pass = 0.02). We found that rs4644 affects galectin-3 as a transcriptional coregulator. Among 34 genes affected by rs4644, HES1, HSPA6, SPC24, and NHS were of particular interest since their expression was rs4644-dependent (CC>AA for the first and AA>CC for the others), also in 574 thyroid tissues of Genotype-Tissue Expression (GTEx) biobank. Moreover, the expression of these genes was regulated by LGALS3-silencing. Using the proximity ligation assay in Nthy-Ori cells, we found that the TTF-1 interaction was genotype dependent. Conclusions: Our data show that in thyroid, rs4644 is a trans-expression quantitative trait locus that can modify the transcriptional expression of downstream genes, through the modulation of TTF-1.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Corrado A, Aceto R, Silvestri R, et al. Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System. Thyroid. 2021. PMID: 33308024. doi:10.1089/thy.2020.0366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。